Dr. Susan Hutchinson joined Dr. Jack Schim for a live Webcast on Thursday evening, October 25th, to discuss Ajovy, the second CGRP monoclonal Antibody approved for migraine prevention. It is an injection and offers the option of quarterly or monthly dosing.
Dr. Hutchinson was 2nd author on an abstract titled "Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study" that was accepted as a poster presentation both at the recent American Headache Society Scientific Symposium in June 2018 and at the Diamond Headache Clinic Research & Educational Foundation in July 2018.
Reader’s Digest Online has included MigraineX and Dr. Hutchinson in an article titled, “The Sneaky Warning Signs a Migraine Is Coming—and How to Stop Them.”
Dr Susan Hutchinson recounts her journey as a doctor who suffers from migraine and how she has learned to manage the condition to improve her quality of life.
